PULSE BIOSCIENCES, INC.
PLSENasdaqHealthcare · Surgical & Medical Instruments & Apparatus · DE · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $350,000 | $0 | $0 | $700,000 | $1.4M | $0 |
| Operating income | −$76.9M | −$56.3M | −$43.6M | −$58.1M | −$63.0M | −$50.0M |
| Net income | −$72.8M | −$53.6M | −$42.2M | −$58.5M | −$63.7M | −$49.9M |
| Total assets | $94.5M | $132.5M | $59.2M | $77.9M | $54.2M | $41.3M |
| Total liabilities | $13.9M | $17.6M | $14.8M | $80.1M | $18.6M | $18.4M |
| Equity | $80.7M | $114.9M | $44.4M | −$2.2M | $35.7M | $22.9M |
| EPS (diluted) | $-1.08 | $-0.92 | $-0.85 | $-1.72 | $-2.28 | $-2.14 |
| Shares out. | 67.3M | 55.2M | 37.6M | 29.8M | 26.1M | 20.8M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- −21982.6%
- Net margin
- −20794.6%
- Return on equity
- −90.2%
- Return on assets
- −77.0%
- Return on capital (ROCE)
- −88.8%
- Liabilities / assets
- 14.7%
- Debt / equity
- 0.17×
- Book value / share
- $1.20
- Revenue growth (YoY)
- —
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- -10.11distress
- Accruals / assets
- −19.7%clean
- Piotroski F-Score
- 2/8weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 2 severe● 3 warning● 2 good- Altman Z″ in the distress zone
- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating losses (negative operating margin)
- Reported a net loss
- Negative operating cash flow
- Conservative leverage (liabilities < 50% of assets)
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗Aug 15, 2024
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Duggan Robert WActivist (13D)May 13, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Laviolette Paul AOfficer — Chief Executive Officer | May 11, 2026 | Buy | 15,000 | $19.69 |
| Duggan Robert WDirector | May 11, 2026 | Buy | 660,233 | $19.69 |
| Danahy Kevin PatrickOfficer — Chief Commercial Officer | Feb 18, 2026 | Option exercise | 5,000 | $1.53 |
| Danahy Kevin PatrickOfficer — Chief Commercial Officer | Feb 12, 2026 | Option exercise | 20,000 | $1.53 |
| Danahy Kevin PatrickOfficer — Chief Commercial Officer | Feb 9, 2026 | Option exercise | 20,000 | $1.53 |
| Danahy Kevin PatrickOfficer — Chief Commercial Officer | Oct 2, 2025 | Option exercise | 4,600 | $1.53 |
| Danahy Kevin PatrickOfficer — Chief Commercial Officer | Sep 18, 2025 | Option exercise | 20,000 | $1.53 |
| Uecker DarrinOfficer — Chief Technology Officer | Sep 16, 2025 | Option exercise | 25,000 | $4.00 |
| Uecker DarrinOfficer — Chief Technology Officer | Sep 11, 2025 | Option exercise | 25,000 | $4.00 |
| Duggan Robert WDirector | Sep 10, 2025 | Buy | 34,659 | $14.66 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 3.2M | 6.9 | +10.1% |
| Apr 30, 2026 | 2.9M | 12.1 | +0.6% |
| Apr 15, 2026 | 2.9M | 11.3 | -0.3% |
| Mar 31, 2026 | 2.9M | 11.8 | +11.1% |
| Mar 13, 2026 | 2.6M | 9.8 | +3.6% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Other material eventMay 6, 2026
- Results of operations · Other material eventMay 4, 2026
- Regulation FD disclosureApr 27, 2026
- Regulation FD disclosureApr 16, 2026
- Director / officer change · Regulation FD disclosureApr 9, 2026
- Other material eventApr 7, 2026
- Director / officer changeMar 27, 2026
- Other material eventMar 17, 2026
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- 4/AFORM 4/AMay 15, 2026
- 10-QFORM 10-QMay 14, 2026
- SCHEDULE 13D/AMay 13, 2026
- 4/AATM PURCHASEMay 11, 2026
- 4ATM PURCHASEMay 11, 2026
- 4ATM PURCHASEMay 11, 2026
- DEF 14AFORM DEF 14AMay 11, 2026
- 8-KFORM 8-KMay 6, 2026
- 8-KFORM 8-KMay 4, 2026
- 10-K/AFORM 10-K/AApr 30, 2026
- 8-KFORM 8-KApr 27, 2026
- 8-KFORM 8-KApr 16, 2026
- 8-KFORM 8-KApr 9, 2026
- 8-KFORM 8-KApr 7, 2026
- 4FORM 4, DARRIN (RSU GRANT)Apr 3, 2026
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.